Introduction: Nasdaq Correction and the AI Opportunity The Nasdaq Composite has slipped into a correction phase, prompting investors to reassess ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

Demis Hassabis (DeepMind CEO) and other AI leaders sees the next big AI gains—and the path to AGI—will come from targeted ...

Bloom’s Taxonomy has long been a tool educators could use to identify levels of cognitive demand in the classroom. Originally ...

The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in Intelligent Medicine (February 2026, Volume 6, Issue 1), ...

These days, it seems like every tech company and their corporate parent is looking to squeeze AI tools and features into ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

Black Forest Labs has long punched above its weight in the AI image generation space. Its next move? Powering physical AI.

How does the brain create mental images? A new study reveals that visual imagination and perception share a common neural code.

Researcher Andrew Dai believes that the artificial intelligence models at big labs have the intelligence of a 3-year-old kid, ...

Anthropic launched Project Glasswing to help organizations safely use and test its cybersecurity model, Claude Mythos.